ASSOCIATION OF DIABETIC RETINOPATHY WITH CHRONIC KIDNEY DISEASE PROGRESSION IN LATINOS WITH TYPE 2 DIABETES

被引:0
|
作者
Figueroa, Arid E. [1 ]
Roy, Neil [1 ]
Millan-Ferro, Andrcina [2 ]
Silva, Paolo S. [3 ,4 ]
Rosas, Sylvia E. [1 ,2 ,4 ]
机构
[1] Joslin Diabet Ctr, Kidney & Hypertens Unit, Boston, MA USA
[2] Joslin Diabet Ctr, Latino Diabet Initiat, Boston, MA USA
[3] Joslin Diabet Ctr, Beetham Eye Inst, Boston, MA USA
[4] Harvard Med Sch, Boston, MA 02115 USA
基金
美国国家卫生研究院;
关键词
Diabetic Retinopathy; Chronic Kidney Disease; Type; 2; Diabetes; Latinos; COMPLICATIONS; POPULATION; HISPANICS; MELLITUS; RISK;
D O I
10.18865/ed.33.1.9
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Aims: Diabetes remains a leading cause of blindness and kidney failure in the United States. Latinos are at increased risk for type 2 diabetes, and microvascular complications such as diabetic retinopathy (DR) and chronic kidney disease (CKD). We evaluated the association of DRwith decline in kidney function in Latinos with type 2 diabetes with or without CKD in a multispecialty clinic. Methods: This is a retrospective cohort study of 351 self-identified Latino individuals with type 2 diabetes enrolled in the Latino Diabetes Initiative at Joslin Diabetes Center. Baseline demographic factors including age, sex, comorbidities, and laboratory values such as A1c and albuminuria were evaluated as predictors of kidney outcomes. The annualized change in estimated glomerular filtration rate (eGFR) was evaluated with a linear regression model. We used logistic regression to evaluate whether DR was associated with development of rapid progressors (>3 mL/min/y eGFR loss) and 30% change in eGFR per year. Results: DR was present in 39.2% of the cohort with mild nonproliferative DR (NPDR) in 57.1%, moderate to severe NPDR in 27.8%, and proliferative DR in 15.0%. Those with DR had a longer duration of type 2 diabetes (P<.001), higher albuminuria (P=.003), and lower baseline eGFR (P=.001). We found that individuals with moderate to severe NPDR and proliferative DR had a significant decline in GFR (coefficient -6.32; 95% CI, -11.40 to -1.23) and -7.82 (-14.99 to -0.65), compared with individuals without DR. Conclusions: The presence of DR is a marker for increased eGFR loss, emphasizing the need for routine retinal examinations as part of comprehensive diabetes care. Individuals with DR should be considered at high risk for GFR loss.
引用
收藏
页码:9 / 16
页数:8
相关论文
共 50 条
  • [31] Association of Succinate and Adenosine Nucleotide Metabolic Pathways with the Progression of Diabetic Kidney Disease in Patients with Type 2 Diabetes Mellitus
    Jung, Inha
    Nam, Seungyoon
    Park, Soyoung
    Lee, Da Young
    Yu, Ji Hee
    Seo, Ji A.
    Lee, Dae Ho
    Kim, Nan Hee
    DIABETES, 2024, 73
  • [32] Anemia and Diabetic Kidney Disease Had Joint Effect on Diabetic Retinopathy Among Patients With Type 2 Diabetes
    Wang, Jianyong
    Xin, Xing
    Luo, Wenliang
    Wang, Ruojie
    Wang, Xinyi
    Si, Shuting
    Mo, Minjia
    Shao, Bule
    Wang, Shuojia
    Shen, Yu
    Chen, Xi
    Yu, Yunxian
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2020, 61 (14)
  • [33] Progression of diabetic kidney disease and trajectory of kidney function decline in Chinese patients with Type 2 diabetes
    Jiang, Guozhi
    Luk, Andrea On Yan
    Tam, Claudia Ha Ting
    Xie, Fangying
    Carstensen, Bendix
    Lau, Eric Siu Him
    Lim, Cadmon King Poo
    Lee, Heung Man
    Ng, Alex Chi Wai
    Ng, Maggie Chor Yin
    Ozaki, Risa
    Kong, Alice Pik Shan
    Chow, Chun Chung
    Yang, Xilin
    Lan, Hui-yao
    Tsui, Stephen Kwok Wing
    Fan, Xiaodan
    Szeto, Cheuk Chun
    So, Wing Yee
    Chan, Juliana Chung Ngor
    Ma, Ronald Ching Wan
    KIDNEY INTERNATIONAL, 2019, 95 (01) : 178 - 187
  • [34] Prevalence and progression of diabetic retinopathy in people with type 2 diabetes dependent on the duration of diabetes
    Voigt, M.
    Schmidt, S.
    Mueller, N.
    Milke, B.
    Voigt, U. A.
    Wolf, G.
    Mueller, U. A.
    DIABETOLOGIA, 2015, 58 : S520 - S520
  • [35] Onset and progression of diabetic retinopathy within eight years in type 2 diabetes in the Danish Registry of Diabetic Retinopathy
    Grauslund, Jakob
    Pedersen, Frederik
    Andersen, Nis
    Andresen, Jens
    Bek, Toke
    Dinesen, Sebastian
    Hajari, Javad
    Heegaard, Steffen
    Hojlund, Kurt
    Laugesen, Caroline
    Kawasaki, Ryo
    Moller, Soren
    Schielke, Katja
    Thykjaer, Anne Suhr
    Stokholm, Lonny
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2023, 64 (08)
  • [36] Retinopathy Progression in Type 2 Diabetes
    Liew, Gerald
    Wang, Jie Jin
    Mitchell, Paul
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (22): : 2171 - 2172
  • [37] Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
    Wanner, Christoph
    Inzucchi, Silvio E.
    Lachin, John M.
    Fitchett, David
    von Eynatten, Maximilian
    Mattheus, Michaela
    Johansen, Odd Erik
    Woerle, Hans J.
    Broedl, Uli C.
    Zinman, Bernard
    Aizenberg, D.
    Ulla, M.
    Waitman, J.
    De Loredo, L.
    Farias, J.
    Fideleff, H.
    Lagrutta, M.
    Maldonado, N.
    Colombo, H.
    Ferre Pacora, F.
    Wasserman, A.
    Maffei, L.
    Lehman, R.
    Selvanayagam, J.
    d'Emden, M.
    Fasching, P.
    Paulweber, B.
    Toplak, H.
    Luger, A.
    Drexel, H.
    Prager, R.
    Schnack, C.
    Schernthaner, G.
    Fliesser-Goerzer, E.
    Kaser, S.
    Scheen, A.
    Van Gaal, L.
    Hollanders, G.
    Kockaerts, Y.
    Capiau, L.
    Chachati, A.
    Persu, A.
    Hermans, M.
    Vantroyen, D.
    Vercammen, C.
    Van de Borne, P.
    Mathieu, C.
    Benhalima, K.
    Lienart, F.
    Mortelmans, J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (04): : 323 - 334
  • [38] Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
    Wakisaka, Masanori
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (18): : 1799 - 1800
  • [39] Association of plasma osteopontin with diabetic retinopathy in Asians with type 2 diabetes
    Zhang, Xiao
    Chee, Wai Kitt
    Liu, Sylvia
    Tavintharan, Subramaniam
    Sum, Chee Fang
    Lim, Su Chi
    Kumari, Neelam
    MOLECULAR VISION, 2018, 24 : 165 - 173
  • [40] Association of serum magnesium with type 2 diabetes mellitus and diabetic retinopathy
    Kumar, Pratyush
    Bhargava, Seema
    Agarwal, Pankaj Kumar
    Garg, Ambuj
    Khosla, Amit
    JOURNAL OF FAMILY MEDICINE AND PRIMARY CARE, 2019, 8 (05) : 1671 - 1677